Copd assignment

Asking for Preferences

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Searching Images

COPD emphysema chronic bronchitis pathology diagram

Reading File

Finding Sources

Reading File

Here is your comprehensive COPD exam prep Q&A, organised by topic, with answers drawn from Robbins Pathology, Rosen's Emergency Medicine, Katzung Pharmacology, Costanzo Physiology, and the Textbook of Family Medicine.

COPD - Comprehensive Exam Prep Q&A (Undergraduate / Nursing Level)

SECTION 1: DEFINITION & PATHOPHYSIOLOGY

Q1. How is COPD defined according to GOLD? COPD is "a common, preventable and treatable disease characterised by persistent respiratory symptoms and airflow limitation due to airway or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases." The key diagnostic requirement is a post-bronchodilator FEV1/FVC ratio of < 0.70 on spirometry. Clinical symptoms or chest X-ray findings alone are not sufficient to diagnose COPD. (Rosen's Emergency Medicine; Textbook of Family Medicine)

Q2. What are the two conditions that make up COPD, and how do they differ?

Feature	Emphysema	Chronic Bronchitis
Definition	Enlargement of air spaces distal to terminal bronchioles due to destruction of alveolar walls	Productive cough for ≥3 months/year in ≥2 consecutive years
Mechanism	Protease-antiprotease imbalance - neutrophil-released proteases destroy elastic tissue	Mucus hypersecretion from submucosal gland enlargement + goblet cell metaplasia
Blood gases	Relatively normal O2 at rest ("pink puffer")	Hypoxemia + hypercapnia ("blue bloater")
Histology	Destroyed alveolar walls, enlarged air spaces	Enlarged mucus glands, goblet cell metaplasia, bronchiolar wall fibrosis

(Robbins Pathology)

Q3. What is the pathophysiology of airflow obstruction in COPD?

Noxious stimuli (cigarette smoke, pollutants) trigger chronic inflammation with neutrophils, macrophages, and lymphocytes infiltrating airways and parenchyma
Protease/antiprotease imbalance: excess proteases destroy the connective tissue matrix of alveolar walls
Oxidative stress contributes to tissue remodeling
In bronchioles: increased mucus, decreased mucociliary clearance, smooth muscle remodeling, and small airway fibrosis cause fixed obstruction
Result: loss of elastic recoil, air trapping, and dynamic hyperinflation (Rosen's Emergency Medicine)

Q4. What are the two subtypes of emphysema and their causes?

Centriacinar (centrilobular): Most common. Affects the central part of the acinus (respiratory bronchioles). Strongly associated with cigarette smoking.
Panacinar (panlobular): Affects the whole acinus uniformly. Associated with α1-antitrypsin deficiency. (Robbins Pathology)

Q5. Explain the protease-antiprotease mechanism in emphysema. Neutrophils and macrophages recruited by cigarette smoke release elastases and matrix metalloproteinases (proteases). Normally, α1-antitrypsin neutralises these enzymes. In smokers, reactive oxygen species inactivate α1-antitrypsin, tipping the balance toward tissue destruction. In genetic α1-antitrypsin deficiency, this protection is absent from birth, causing early-onset panacinar emphysema. (Robbins Pathology; Textbook of Family Medicine)

SECTION 2: RISK FACTORS

Q6. What are the risk factors for COPD?

Smoking - the most important risk factor (accelerates FEV1 decline from ~30 mL/year to ~60 mL/year)
Age > 40 years
Male gender
Occupational exposures (dust, fumes, chemicals)
Indoor air pollution (cooking over open fires/charcoal)
Secondhand smoke
Genetic: α1-antitrypsin deficiency - suspect this in patients who develop COPD before age 45, without significant smoking history, or with strong family history (Rosen's Emergency Medicine; Textbook of Family Medicine)

Q7. When should you screen for α1-antitrypsin deficiency?

COPD developing before age 45
COPD without significant smoking history
Strong family history of COPD
Predominantly lower lobe emphysema on imaging (Textbook of Family Medicine)

SECTION 3: DIAGNOSIS & GOLD STAGING

Q8. How is COPD diagnosed? Diagnosis requires spirometry-proven airflow limitation:

Post-bronchodilator FEV1/FVC < 0.70
A patient with normal spirometry but chronic symptoms (cough, dyspnea) does NOT have COPD by definition, even if CT shows emphysematous changes (Rosen's Emergency Medicine)

Q9. What are the GOLD grades of airflow obstruction (based on FEV1 % predicted in patients with FEV1/FVC < 0.70)?

GOLD Grade	Severity	FEV1 % Predicted
GOLD 1	Mild	≥ 80%
GOLD 2	Moderate	50-79%
GOLD 3	Severe	30-49%
GOLD 4	Very Severe	< 30%

(GOLD Guidelines, referenced in Katzung Pharmacology and Textbook of Family Medicine)

Q10. What ABG findings are characteristic in a COPD patient? From a classic clinical case (65-year-old with 40-year smoking history):

PaO2 ↓ (e.g., 60 mmHg vs. normal 100 mmHg) - due to V/Q mismatch
PaCO2 may be low in compensating patient (hyperventilation) or elevated in severe/late disease
pH slightly alkaline if hyperventilating (respiratory alkalosis) or acidotic in severe hypercapnic failure (pH < 7.35, PaCO2 > 45)
The A-a gradient (difference between calculated PAO2 and measured PaO2) is widened, indicating V/Q mismatch (Costanzo Physiology)

Q11. What is the classic CXR finding in COPD?

Hyperinflation with flattened diaphragms
Increased AP diameter ("barrel chest")
Note: these findings are suggestive but NOT diagnostic - spirometry is still required for formal diagnosis (Rosen's Emergency Medicine)

SECTION 4: MANAGEMENT OF STABLE COPD

Q12. What is the single most important intervention in COPD management? Smoking cessation. It can halve the rate of FEV1 decline (from ~60 mL/year down to ~30 mL/year). This is the cornerstone of treatment at every stage. Combined interventions (counselling + pharmacotherapy with nicotine replacement or bupropion) achieve ~25% long-term quit rates. (Textbook of Family Medicine)

Q13. What bronchodilators are used in stable COPD?

Drug Class	Examples	Use
Short-acting β2-agonist (SABA)	Salbutamol (albuterol)	Rescue/PRN for acute symptoms
Short-acting anticholinergic	Ipratropium bromide	Acute or regular use
SABA + anticholinergic combined	Albuterol + ipratropium	Acute symptom relief
Long-acting β2-agonist (LABA)	Salmeterol, formoterol	Persistent exertional dyspnea
Long-acting anticholinergic (LAMA)	Tiotropium	Persistent symptoms; preferred maintenance
LABA + LAMA combination	-	For persistent symptoms on monotherapy

(Katzung Pharmacology)

Q14. What is the role of inhaled corticosteroids (ICS) in COPD? ICS has a less central role in COPD than in asthma because:

Lower efficacy in COPD (neutrophilic rather than eosinophilic inflammation)
Associated with increased risk of bacterial pneumonia

ICS is recommended only for:

Severe airflow obstruction
Frequent exacerbation history
High blood eosinophil count (suggests ICS benefit)
Clear overlap with asthma

(Katzung Pharmacology)

Q15. What is roflumilast and when is it used? Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor (non-methylxanthine). It improves pulmonary function and reduces exacerbation frequency. Approved for COPD patients with chronic bronchitis and frequent exacerbations. (Katzung Pharmacology)

Q16. What vaccines are mandatory for COPD patients?

Influenza vaccine: every year - reduces hospitalisation and death by 30-40%
Pneumococcal vaccine: all COPD patients; revaccinate after 10 years if first dose was given before age 65 (Textbook of Family Medicine)

Q17. What non-pharmacological interventions are used in COPD?

Pulmonary rehabilitation: improves exercise tolerance and health status (St. George's Respiratory Questionnaire scores improve); does not reduce mortality
Long-term oxygen therapy (LTOT): for patients with resting PaO2 ≤ 55 mmHg, or ≤ 59 mmHg with cor pulmonale/polycythaemia; minimum 15-18 hours/day; indicated for hypercapnic patients (PaCO2 > 55 mmHg)
Nutritional support: vitamin E/beta-carotene supplements have NOT been shown to improve outcomes
Lung volume reduction surgery (LVRS): in selected patients with FEV1 < 30-40% predicted; improves quality of life but not 5-year mortality (Textbook of Family Medicine)

SECTION 5: ACUTE EXACERBATIONS

Q18. Define a COPD exacerbation. An acute exacerbation of COPD (AECOPD) is a worsening of symptoms beyond normal day-to-day variation that requires a change in treatment. Key symptoms include:

Increased dyspnoea
Increased cough
Increased sputum production
Increased sputum purulence (Rosen's Emergency Medicine)

Q19. What triggers COPD exacerbations?

Viral respiratory infections (most common trigger)
Bacterial infections - Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae
Environmental: secondhand smoke, air pollution, ozone, dust, pet dander
Intercurrent illness, fatigue, weather change (in severe disease with minimal pulmonary reserve) (Textbook of Family Medicine)

Q20. What is the management of a COPD exacerbation in the ED? First-line treatment:

Short-acting bronchodilators: nebulised albuterol (SABA) + ipratropium (anticholinergic)
Systemic corticosteroids: oral prednisolone or IV methylprednisolone (oral has equivalent bioavailability/efficacy - avoid oral only if patient has respiratory distress)
Antibiotics: routinely used because exacerbations frequently involve bacterial infection - β-lactams, doxycycline, or macrolides are commonly used
Controlled oxygen: target SpO2 88-92% (avoid hyperoxia which can worsen hypercapnia in CO2-retaining patients)
Non-invasive ventilation (NIV/BiPAP): for respiratory failure with acidosis (pH < 7.35, PaCO2 elevated) (Rosen's Emergency Medicine; Katzung Pharmacology)

Q21. When is non-invasive ventilation (NIV/BiPAP) indicated in COPD? In a patient with:

Respiratory failure
pH < 7.35 with elevated PaCO2
Respiratory rate > 25, increased WOB
Awake and able to protect airway (no clear contraindications)

Example from Rosen's: A 64-year-old COPD patient, RR 50, pH 7.25, PaCO2 70 mmHg, SpO2 88% on 8 L/min - next step is noninvasive bi-level positive pressure ventilation (BiPAP), not immediate intubation. (Rosen's Emergency Medicine)

Q22. Why is rapid shallow breathing dangerous in COPD exacerbation? Rapid shallow breathing:

Decreases exhalation time → causes dynamic hyperinflation (air trapping)
Increases the proportion of dead space ventilation → causes hypercapnia and respiratory muscle fatigue If untreated, this progresses to respiratory failure. (Rosen's Emergency Medicine)

Q23. When mechanically ventilating a COPD patient, what initial settings reduce auto-PEEP?

Tidal volume: 8 mL/kg predicted body weight
Respiratory rate: 10-14 breaths/min
This prevents auto-PEEP (intrinsic PEEP/dynamic hyperinflation) from developing, which can cause haemodynamic collapse (Rosen's Emergency Medicine)

SECTION 6: COMPLICATIONS

Q24. What are the major complications of COPD?

Cor pulmonale: Right-sided heart failure from chronic pulmonary hypertension secondary to hypoxic vasoconstriction
Respiratory failure: Type 1 (hypoxaemia) or Type 2 (hypoxaemia + hypercapnia)
Secondary polycythaemia: chronic hypoxia stimulates EPO → elevated RBC mass
Spontaneous pneumothorax: rupture of emphysematous bullae
Lung cancer: shared risk factor (smoking); COPD itself increases risk independently
Comorbidities: ischaemic heart disease, atrial fibrillation, heart failure, metabolic syndrome, anxiety, depression (Rosen's Emergency Medicine; Robbins Pathology)

Q25. What is the "barrel chest" and why does it occur? Barrel chest is an increase in the anteroposterior (AP) diameter of the chest. It results from air trapping and chronic hyperinflation in emphysema - the lungs remain over-distended and the chest wall remodels accordingly. It is a classic clinical sign of advanced COPD/emphysema. (Costanzo Physiology)

SECTION 7: HIGH-YIELD NURSING POINTS

Q26. What is the target SpO2 in a COPD patient receiving oxygen therapy? 88-92% - NOT the standard 94-98% target used for most patients. In chronic CO2 retainers, the hypoxic drive (not hypercapnic drive) may be maintaining their ventilation. Excessive oxygen can suppress this drive, worsen hypercapnia, and precipitate respiratory failure. Always use controlled low-flow oxygen.

Q27. What nursing assessments are priorities in a COPD patient?

Respiratory rate, depth, and effort (accessory muscle use, pursed-lip breathing)
SpO2 (target 88-92%)
ABG results (pH, PaO2, PaCO2)
Sputum colour/quantity (purulent = likely bacterial exacerbation)
Level of consciousness (early sign of CO2 retention = confusion/drowsiness)
Signs of cor pulmonale: peripheral oedema, raised JVP

Q28. What does pursed-lip breathing do? Creates back-pressure in the airways, which helps prevent dynamic airway collapse during exhalation in emphysema, improving air outflow and reducing air trapping. Patients often adopt this naturally.

Q29. What patient education should a COPD patient receive?

Stop smoking (most important)
Use inhalers correctly (technique matters - check spacer use)
Annual flu and pneumococcal vaccines
Recognise early signs of exacerbation (increased dyspnoea, change in sputum)
Pulmonary rehabilitation programme
Maintain adequate nutrition
Discuss advance care planning in severe disease (Textbook of Family Medicine)

QUICK-REFERENCE SUMMARY TABLE

Feature	Key Point
Diagnostic gold standard	Post-bronchodilator FEV1/FVC < 0.70
Most important risk factor	Cigarette smoking
Genetic risk factor	α1-antitrypsin deficiency
Chronic bronchitis definition	Productive cough ≥3 months/year for ≥2 years
Emphysema mechanism	Protease-antiprotease imbalance → alveolar wall destruction
GOLD 1/2/3/4 FEV1	≥80% / 50-79% / 30-49% / <30%
Most important treatment	Smoking cessation
First-line bronchodilator	SABA ± SAMA (albuterol ± ipratropium)
Maintenance drug	LAMA (tiotropium)
ICS - when to use?	Severe/frequent exacerbations + high eosinophils
Oxygen target SpO2	88-92% (not higher)
NIV indication	pH < 7.35, PaCO2 elevated, no contraindications
Exacerbation treatment	Bronchodilators + steroids + antibiotics ± NIV
Key complication	Cor pulmonale, Type 2 respiratory failure

Sources: Robbins & Kumar Basic Pathology; Rosen's Emergency Medicine; Katzung's Basic and Clinical Pharmacology (16th ed.); Costanzo Physiology (7th ed.); Textbook of Family Medicine (9th ed.)

Cervical assignment of ridicular pathy

Asking for Preferences

Reading File

Finding Sources

Reading File

Finding Sources

Searching Images

cervical radiculopathy dermatome nerve root levels C5 C6 C7

Reading File

Finding Sources

Reading File

I now have comprehensive content from five authoritative sources. Let me now compile the full exam Q&A.

Cervical Radiculopathy - Comprehensive Exam Prep Q&A

Sources: Bradley & Daroff's Neurology in Clinical Practice; Harrison's Principles of Internal Medicine (22nd ed.); Tintinalli's Emergency Medicine; Firestein & Kelley's Textbook of Rheumatology; Miller's Review of Orthopaedics (9th ed.)

SECTION 1: DEFINITION & ANATOMY

Q1. What is cervical radiculopathy? Cervical radiculopathy is a clinical syndrome caused by compression or irritation of a cervical nerve root, resulting in radiating pain, sensory changes (numbness, paresthesias, dysesthesias), and/or motor weakness in the distribution of the affected root. It must be distinguished from cervical myelopathy (spinal cord compression), which carries more serious consequences. (Bradley & Daroff's Neurology)

Q2. What are the two main structural causes of cervical radiculopathy and how do they differ by age?

Cause	Typical Age Group	Mechanism
Soft disc herniation (HNP)	< 45 years	Nucleus pulposus protrudes through the posterior annulus fibrosus, usually posterolaterally
Spondylosis / neuroforaminal stenosis (hard disc / osteophytes)	> 45-50 years	Chronic degenerative changes - disc space narrowing, osteophyte formation, facet/uncovertebral joint hypertrophy narrow the neural foramen

Most cases become symptomatic without an identifiable traumatic event. (Bradley & Daroff's Neurology)

Q3. What is the anatomy of cervical nerve roots - which root exits at which level? In the cervical spine, nerve roots exit above their corresponding vertebra (unique to the cervical spine):

The C6 root exits at the C5-C6 disc level
The C7 root exits at the C6-C7 disc level
The C8 root exits at the C7-T1 disc level

The most commonly involved levels are C5-C6 (C6 root) and C6-C7 (C7 root) because these are the levels of greatest mobility and most disc degeneration. (Tintinalli's Emergency Medicine; Bradley & Daroff's)

SECTION 2: DERMATOMAL LEVELS - HIGH YIELD TABLE

Q4. What are the specific findings for each cervical root level?

Root	Disc Level	Pain/Sensory Area	Weakness	Reflex Lost
C5	C4-C5	Shoulder, lateral upper arm	Deltoid, biceps, brachioradialis	Biceps, brachioradialis (supinator)
C6	C5-C6	Lateral forearm, thumb, index finger	Brachioradialis, wrist extensors	Biceps, brachioradialis
C7	C6-C7	Index, middle, ring fingers; posterior forearm	Triceps, wrist flexors, pronators	Triceps
C8	C7-T1	Little finger, medial forearm	Intrinsic hand muscles, finger flexors	None (finger flexors)
T1	T1-T2	Medial upper arm	Intrinsic hand muscles	None

Tip: C5, C6, C7 are the three most commonly involved roots in cervical spondylosis - they sit at the most mobile segments. (Bradley & Daroff's Neurology)

Q5. What is subscapular / interscapular pain and which root causes it? Subscapular or interscapular pain is a classic presentation of lower cervical radiculopathy, most commonly C7, but also C6, C8, and/or T1. Patients often describe a deep, aching pain between the shoulder blades that can mislead clinicians toward a cardiac or musculoskeletal diagnosis. (Bradley & Daroff's Neurology)

SECTION 3: CAUSES & RISK FACTORS

Q6. What are the causes of cervical radiculopathy?

Herniated nucleus pulposus (HNP) - "soft disc" - posterolateral herniation most common; direct posterior herniation can cause myelopathy
Cervical spondylosis - degenerative disc disease, osteophytes, facet joint hypertrophy, uncovertebral (Luschka) joint hypertrophy narrowing the foramen ("hard disc")
Non-compressive causes: diabetic radiculopathy, herpes zoster (shingles), leptomeningeal metastases, Lyme disease
Traumatic (fracture, disc disruption)
Tumour - metastatic disease (breast, lung, prostate, lymphoma, myeloma) - suspect with unrelenting night pain and age > 50 (Tintinalli's Emergency Medicine; Firestein & Kelley's)

Q7. What degenerative changes constitute cervical spondylosis on imaging? Spondylosis is radiographically diagnosed if any one of three findings is present:

Osteophytes
Disc space narrowing
Facet joint disease

Important caveat: spondylosis is highly prevalent in asymptomatic individuals - imaging findings must always be correlated with clinical symptoms. (Tintinalli's Emergency Medicine)

SECTION 4: CLINICAL PRESENTATION

Q8. What are the classic symptoms of cervical radiculopathy?

Radicular pain: neck pain radiating down the arm in a dermatomal pattern - often sharp and shooting
Paresthesias / dysesthesias / numbness in the distribution of the affected root
Weakness in the corresponding myotome
Pain is aggravated by:
- Coughing or Valsalva maneuver (increases intraspinal pressure)
- Neck extension + rotation toward the painful side + axial compression (Spurling's maneuver)
Subscapular / interscapular pain is common with lower cervical roots (C7 especially) (Bradley & Daroff's Neurology)

Q9. What is the Spurling maneuver/test and what does a positive result mean? The examiner places the patient's head in extension + rotation toward the symptomatic side, then applies downward axial compression on the head. A positive Spurling's sign reproduces the patient's radicular arm pain. It narrows the neural foramen, compressing the affected root. It has high specificity for cervical radiculopathy. (Tintinalli's Emergency Medicine; Firestein & Kelley's)

Q10. How does cervical distraction relieve symptoms? Manual cervical distraction in flexion (examiner gently lifts the head upward) alleviates radicular symptoms by widening the neural foramen and reducing nerve root compression. This is the opposite of Spurling's test. (Tintinalli's Emergency Medicine)

Q11. What are the features of myelopathy that distinguish it from radiculopathy?

Feature	Radiculopathy	Myelopathy
Level of lesion	Nerve root (PNS)	Spinal cord (CNS)
Reflexes	Diminished/absent at affected level	Hyperreflexia (below lesion)
Plantar response	Flexor (normal)	Babinski sign (extensor)
Gait	Normal	Broad-based, spastic gait
Hoffmann's sign	Negative	Positive
Sphincter control	Preserved	May be lost (rare)
Fine motor skills	Preserved	Deteriorated

The presence of hyperreflexia, Hoffmann's sign, or Babinski's sign indicates cord compression (myelopathy) and requires urgent surgical referral. (Firestein & Kelley's; Tintinalli's Emergency Medicine)

Q12. What is the "paradoxical biceps reflex" and what does it indicate? The paradoxical biceps reflex occurs when the biceps reflex is absent or reduced (from C5/C6 root compression), but tapping the biceps tendon instead produces reflex contraction of the finger flexors, or rarely the triceps. It indicates the presence of myelopathy in addition to radiculopathy. (Bradley & Daroff's Neurology)

SECTION 5: DIAGNOSIS & INVESTIGATIONS

Q13. What is the investigation of choice for cervical radiculopathy? MRI of the cervical spine is the imaging modality of choice. It:

Identifies nerve root compression and the level of involvement
Diagnoses disc herniation vs. spondylotic foraminal narrowing
Detects myelopathy (cord signal changes on T2-weighted images)
Excludes other diagnoses (tumour, infection, demyelination)

Plain cervical X-ray is of little value in diagnosing or excluding cervical radiculopathy. (Bradley & Daroff's Neurology)

Q14. When is CT myelography preferred over MRI? CT myelography (CT with intrathecal contrast) is preferred when:

Patient has MRI-incompatible pacemaker or spinal cord stimulator
Severe claustrophobia
Prior cervical spine fusion with hardware (metal degrades MRI images)
Need to distinguish non-calcified disc herniation from osteophytes

Note: MRI is better at showing nerve root compression lateral to the subarachnoid space (outside the contrast-filled region). (Bradley & Daroff's Neurology)

Q15. What is the role of EMG and nerve conduction studies (NCS) in cervical radiculopathy? EMG/NCS are useful in difficult diagnostic cases to:

Identify the affected motor nerve root and myotome
Help exclude brachial plexopathy or peripheral neuropathy

Classic NCS pattern in cervical radiculopathy:

Loss of amplitude in the compound muscle action potential (CMAP)
Preservation of sensory nerve action potential (SNAP) - because the dorsal root ganglion (DRG) lies outside the intervertebral foramen; the sensory cell bodies are intact

Limitations:

Low yield in the hyperacute period - wait for Wallerian degeneration to complete (5-6 days for motor, 8-9 days for sensory fibres)
Needle EMG alone has only 50-71% sensitivity
Demyelinating radiculopathy without axonal loss may give a normal EMG despite symptoms (Bradley & Daroff's Neurology)

Q16. What is the spinal canal diameter threshold for concern on plain lateral X-ray?

Canal Diameter	Interpretation
≥ 14 mm	Normal
10-13 mm	Relative stenosis
< 10 mm	Absolute stenosis (cord compromise likely)

Measured on lateral plain film from the posterior aspect of the vertebral body to the spinolaminar line. (Miller's Review of Orthopaedics)

SECTION 6: DIFFERENTIAL DIAGNOSIS

Q17. What are the differential diagnoses of cervical radiculopathy?

Cervical myelopathy - spinal cord compression (hyperreflexia, Babinski, Hoffmann)
Brachial plexopathy / brachial neuritis (Parsonage-Turner syndrome) - acute severe shoulder pain followed by patchy weakness and atrophy; EMG confirms
Peripheral nerve entrapment - carpal tunnel (median nerve), cubital tunnel (ulnar nerve)
Thoracic outlet syndrome - compression of brachial plexus/vessels; vague shoulder pain with ulnar digit numbness
Shoulder pathology - rotator cuff disease, calcific tendinitis; injection of local anaesthetic helps differentiate
Cardiac referred pain - chest pain mimicking angina (especially anterior osteophytes or lower cervical disease)
Metastatic spine cancer - unrelenting night pain, age > 50, history of malignancy
Infection - epidural abscess, discitis, osteomyelitis (IVDU, immunocompromise)
Herpes zoster - dermatomal pain with rash
Diabetic radiculopathy (Tintinalli's Emergency Medicine; Firestein & Kelley's)

SECTION 7: MANAGEMENT

Q18. What is the natural history of cervical radiculopathy? The prognosis is generally favourable. Most patients with acute cervical radiculopathy improve significantly over 4-8 weeks regardless of treatment. Clinical improvement over time, regardless of therapeutic intervention, is common. (Bradley & Daroff's Neurology; Harrison's)

Q19. What is the first-line (conservative) treatment? In the absence of myelopathy or progressive weakness, first-line treatment is:

Activity modification - avoid movements that exacerbate symptoms
NSAIDs - first-line analgesic/anti-inflammatory
Acetaminophen (paracetamol) - adjunct or alternative
Muscle relaxants - for associated muscle spasm
Short-course oral corticosteroids (e.g., methylprednisolone or prednisone 7-10 day taper) - commonly prescribed for acute radiculopathy; note: efficacy not rigorously proven in trials
Soft cervical collar - modestly helpful by limiting neck movement; hard collars poorly tolerated; semi-rigid collar provides < 20% reduction in range of motion
Physical therapy: gentle supervised exercise, cervical traction
Opioids: for short courses in the ED or outpatient in severe pain (Harrison's Principles; Tintinalli's Emergency Medicine; Bradley & Daroff's)

Q20. What is the role of epidural steroid injections (ESI)? Epidural steroid injections (ESI) may be effective for chronic cervical radiculopathy when other treatments have failed. However, the risk of injection-related complications is higher in the neck than the low back, including:

Vertebral artery dissection
Dural puncture
Spinal cord injury
Embolism in the vertebral arteries (Harrison's Principles)

Q21. What are the indications for surgery? Surgery is indicated when:

Progressive motor deficit due to nerve root compression
Functionally limiting pain that fails to respond to conservative management (typically ≥ 6-12 weeks of conservative treatment)
Recurrent symptoms with concordant imaging findings
Signs of myelopathy (hyperreflexia, Hoffmann's, Babinski, gait disturbance)
Intractable radicular pain unresponsive to treatment (Harrison's Principles; Tintinalli's Emergency Medicine)

Q22. What are the surgical options for cervical radiculopathy?

Anterior cervical discectomy and fusion (ACDF) - most common approach
Total disc arthroplasty (disc replacement) - alternative to fusion
Posterior cervical laminoforaminotomy - direct foramen decompression from the back
For myelopathy: laminectomy, laminoplasty, laminectomy + fusion

Risk of adjacent segment disease after fusion: ~3% per year / ~26% per decade. (Harrison's Principles; Bradley & Daroff's)

Q23. What is a warning sign that prompts urgent/emergency intervention? Red flags requiring urgent referral / hospital admission:

Progressive upper extremity weakness (especially C7 distribution)
Acute or progressive myelopathy (bowel/bladder dysfunction, gait disturbance, bilateral signs)
Night pain / rest pain - suspect malignancy or infection
Signs of epidural abscess or cord compression (fever, ESR elevation, neurological deterioration) (Tintinalli's Emergency Medicine)

Q24. Why should aggressive chiropractic neck manipulation be used with caution? Aggressive chiropractic cervical manipulation can cause vertebral artery dissection at the atlantoaxial (AA) loop, resulting in vertebrobasilar distribution embolic strokes. It should be discouraged, particularly in elderly patients with significant spondylosis. (Bradley & Daroff's Neurology)

SECTION 8: HIGH-YIELD SUMMARY TABLE

Feature	Key Point
Most common levels	C5-C6 (C6 root) and C6-C7 (C7 root)
Cause in young (< 45)	Soft disc herniation (HNP)
Cause in older (> 45)	Spondylosis / neuroforaminal stenosis
Key provocative test	Spurling's sign (extension + rotation + axial compression)
Key relieving maneuver	Cervical distraction in flexion
Imaging of choice	MRI cervical spine
Plain X-ray	NOT useful for diagnosis
EMG pattern	CMAP loss + SNAP preserved
Natural history	Most resolve in 4-8 weeks
First-line treatment	NSAIDs + activity modification + physical therapy
Surgery indications	Progressive weakness, failed conservative, myelopathy
Myelopathy signs	Hyperreflexia, Hoffmann's, Babinski, spastic gait
Red flag: cancer	Night pain, age > 50, known malignancy
Complication of ESI	Vertebral artery dissection
Complication of chiropractic	Vertebrobasilar stroke

SECTION 9: PRACTICE MCQs

MCQ 1. A 38-year-old man presents with sharp right arm pain radiating to the thumb and index finger, with reduced biceps reflex and weak brachioradialis. Which nerve root is most likely affected?

A. C5
B. C6 ✓
C. C7
D. C8

Explanation: C6 compression causes sensory changes in the first two digits, weakness of brachioradialis and wrist extensors, and loss of the biceps/brachioradialis reflex.

MCQ 2. A 52-year-old woman with cervical radiculopathy has EMG performed 3 days after symptom onset. The result is normal. The most likely explanation is:

A. No nerve root is affected
B. The test was performed incorrectly
C. Wallerian degeneration is not yet complete ✓
D. She has demyelinating disease

Explanation: EMG has low yield in the hyperacute period. Allow 5-6 days for motor fibre and 8-9 days for sensory fibre Wallerian degeneration before testing.

MCQ 3. A 60-year-old with neck pain and arm tingling has MRI showing C6-C7 disc protrusion with nerve root compression. He also has brisk lower limb reflexes, Babinski's sign, and wide-based gait. The most important next step is:

A. NSAIDs and physiotherapy
B. Epidural steroid injection
C. Urgent surgical referral for myelopathy ✓
D. Repeat MRI in 6 weeks

Explanation: Signs of cord compression (myelopathy) require urgent surgical evaluation regardless of radiculopathy.

MCQ 4. The Spurling test is positive when cervical radicular pain is reproduced by:

A. Cervical distraction in flexion
B. Extension + rotation to painful side + axial compression ✓
C. Shoulder abduction relief test
D. Valsalva maneuver alone

MCQ 5. Which NCS finding is most characteristic of cervical radiculopathy?

A. Reduced SNAP with normal CMAP
B. Both CMAP and SNAP reduced
C. Reduced CMAP with preserved SNAP ✓
D. Normal CMAP and SNAP with abnormal F-waves only

Explanation: The dorsal root ganglion lies in the intervertebral foramen or outside it; sensory cell bodies are spared in a root lesion, so SNAP is preserved even when the sensory axon is affected distally.

Sources used: Bradley & Daroff's Neurology in Clinical Practice; Harrison's Principles of Internal Medicine 22E (2025); Tintinalli's Emergency Medicine (comprehensive study guide); Firestein & Kelley's Textbook of Rheumatology; Miller's Review of Orthopaedics 9th Edition

This is a shared conversation. Sign in to Orris to start your own chat.